6-fluoro-N-[(5-fluoro-2-methoxypyridin-3-yl)methyl]-5-[(5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]pyridin-2-amine
| CAS No. | 1303420-67-8 |
|---|---|
| MDL No. | MFCD32201039 |
| MF | C21H19F2N5O |
| MW | 395.40 |
| InChI Key | NSMOZFXKTHCPTQ-UHFFFAOYSA-N |
| CAS No. | 1303420-67-8 |
|---|---|
| MDL No. | MFCD32201039 |
| MF | C21H19F2N5O |
| MW | 395.40 |
| InChI Key | NSMOZFXKTHCPTQ-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
PLX5622 is a highly selective, brain-penetrant, orally active CSF1R inhibitor with desirable PK properties across various animals. It enables extended and specific elimination of microglial cells during and preceding pathology development, and is primarily administered via a feed-free diet.
| CAS No. | 1303420-67-8 |
|---|---|
| Product Name | 6-fluoro-N-[(5-fluoro-2-methoxypyridin-3-yl)methyl]-5-[(5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]pyridin-2-amine |